Babson brings full panel diagnostic blood testing to the retail pharmacy counter, making it easier, faster & less invasive for customers to monitor their health.
-
Oct 07, 2024
-
DZD is a Massachusetts-based biotechnology company that offers solutions such as infectious disease diagnosis and genomic sequencing for bloodstream infections.
$21M
Feb 08, 2022
-
Vicarious Surgical is a Massachusetts-based medical device company that manufactures and supplies surgical robotic systems for the healthcare industry.
$142M
Sep 08, 2021
-
MedAware is a cloud platform that utilizes big data algorithms to identify and eliminate prescription errors for healthcare providers and pharmacies.
$8M
Aug 15, 2017
-
DiabetOmics engages in the non-invasive assessment and management of personalized health, diabetes risk, progression and complications.
$4.8M
Feb 21, 2016
-
Frequently Asked Questions about BD
What is BD investing in?
BD has invested in 5 companies including Babson Diagnostics, DZD and Vicarious Surgical
What company did BD invest in?
BD invested in a total 5 companies including Babson Diagnostics, DZD and Vicarious Surgical
What are the top 5 investments by BD?
The top companies in which BD invested are Babson Diagnostics, DZD, Vicarious Surgical, MedAware and Diabetomics
